Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,841 across all filing types
Latest filing 2018-12-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
澄清公告
Regulatory Filings Classification · 95% confidence The document is a clarification announcement by a company addressing rumors about its production lines and financial data of a subsidiary. It contains no financial statements or detailed financial performance data typical of annual or interim reports. It is not a report itself but a public clarification or regulatory announcement to correct misinformation. The document length is short (1975 characters), and it serves as a disclosure to investors and the public. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-12-04 Chinese
关于控股股东增持公司股份的进展公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of a controlling shareholder's share increase in the company. It details the number of shares acquired, the percentage of total shares, the purpose of the increase, and the implementation period. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal disclosure of a shareholder's transaction activity, specifically the increase in shareholding by a major shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2018-11-19 Chinese
2018年第三季度报告全文
Interim / Quarterly Report Classification · 98% confidence The document is titled "普洛药业股份有限公司 2018 年第三季度报告全文" which translates to "Puluo Pharmaceutical Co., Ltd. 2018 Third Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2018. The presence of quarterly financial statements and comprehensive financial analysis indicates this is a quarterly financial report. The document length is about 15,000 characters, which is consistent with a full interim/quarterly report rather than a brief announcement or summary. There is no indication that this is an annual report or an earnings release (which would be shorter and less detailed). It is not a certification or attestation document, nor is it an announcement of report publication. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-10-25 Chinese
2018年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 Third Quarter Report" of 普洛药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, net profit, revenue, cash flow, and other financial indicators for the third quarter of 2018. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. The document length is 7319 characters, which is sufficient to contain substantive financial data, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2018
2018-10-25 Chinese
关于控股子公司获得政府奖励的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding government rewards received by its subsidiaries. It details the amounts, dates, and accounting treatment of these rewards and their expected positive impact on the company's profit for the year 2018. The document is short (1785 characters) and does not contain comprehensive financial statements or detailed financial analysis. It is an announcement of a specific event affecting the company's financials rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-10-12 Chinese
2018年度前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2018, providing estimated net profit and earnings per share figures for the period ending September 30, 2018. It explicitly states that the financial data is unaudited and preliminary, with detailed data to be disclosed in the official third quarter report. This is a typical earnings release or earnings forecast document, not a full interim report containing actual audited financial statements. The document length is short (963 characters), and it provides key highlights of expected financial results rather than comprehensive financial statements or analysis. Therefore, it fits the definition of an Earnings Release (ER). 9M 2018
2018-10-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.